no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Adolescents’ awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary
|
Marek, Erika |
|
2011 |
29 |
47 |
p. 8591-8598 8 p. |
article |
2 |
Age-related changes in durability and function of vaccine-elicited influenza-specific CD4+ T-cell responses
|
Mahnke, Yolanda D. |
|
2011 |
29 |
47 |
p. 8606-8614 9 p. |
article |
3 |
A heat shock protein based polyvalent vaccine targeting HSV-2: CD4+ and CD8+ cellular immunity and protective efficacy
|
Mo, Annie |
|
2011 |
29 |
47 |
p. 8530-8541 12 p. |
article |
4 |
A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health
|
Francis, Shelley A. |
|
2011 |
29 |
47 |
p. 8760-8765 6 p. |
article |
5 |
Bone marrow vaccination: A novel approach to enhance antigen specific antitumor immunity
|
Fresnay, Stephanie |
|
2011 |
29 |
47 |
p. 8599-8605 7 p. |
article |
6 |
Bovine respiratory syncytial virus ISCOMs—Immunity, protection and safety in young conventional calves
|
Hägglund, Sara |
|
2011 |
29 |
47 |
p. 8719-8730 12 p. |
article |
7 |
Burden and prevention of viral hepatitis in Bulgaria
|
FitzSimons, David |
|
2011 |
29 |
47 |
p. 8471-8476 6 p. |
article |
8 |
Comparative evaluation of the antibody in lymphocyte supernatant (ALS) and enzyme-linked immunospot (ELISPOT) assays for measuring mucosal immune responses to Shigella antigens
|
Feller, Andrea J. |
|
2011 |
29 |
47 |
p. 8487-8489 3 p. |
article |
9 |
Construction and immunogenicity of recombinant adenovirus expressing ORF2 of PCV2 and porcine IFN gamma
|
Genmei, Liu |
|
2011 |
29 |
47 |
p. 8677-8682 6 p. |
article |
10 |
Economic evaluation of second generation pneumococcal conjugate vaccines in Norway
|
Robberstad, Bjarne |
|
2011 |
29 |
47 |
p. 8564-8574 11 p. |
article |
11 |
Editorial Board
|
|
|
2011 |
29 |
47 |
p. CO2- 1 p. |
article |
12 |
Efficient induction of anti-tumor immunity by a TAT-CEA fusion protein vaccine with poly(I:C) in a murine colorectal tumor model
|
Park, Jung-Sun |
|
2011 |
29 |
47 |
p. 8642-8648 7 p. |
article |
13 |
Exploiting mucosal surfaces for the development of mucosal vaccines
|
Meeusen, Els N. |
|
2011 |
29 |
47 |
p. 8506-8511 6 p. |
article |
14 |
Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys
|
Hu, Haixia |
|
2011 |
29 |
47 |
p. 8624-8633 10 p. |
article |
15 |
Humoral immune response of a pneumococcal conjugate vaccine: Capsular polysaccharide serotype 14—Lysine modified PspA
|
Santamaria, Raquel |
|
2011 |
29 |
47 |
p. 8689-8695 7 p. |
article |
16 |
Identification and immunogenicity of Mannheimia haemolytica S1 outer membrane lipoprotein PlpF
|
Ayalew, Sahlu |
|
2011 |
29 |
47 |
p. 8712-8718 7 p. |
article |
17 |
Identification of a new protective antigen of Bordetella pertussis
|
Alvarez Hayes, Jimena |
|
2011 |
29 |
47 |
p. 8731-8739 9 p. |
article |
18 |
Immortalized chick embryo cell line adapted to serum-free growth conditions and capable of replicating human and reassortant H5N1 influenza strains for vaccine production
|
Coussens, Paul M. |
|
2011 |
29 |
47 |
p. 8661-8668 8 p. |
article |
19 |
Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children
|
Phongsamart, Wanatpreeya |
|
2011 |
29 |
47 |
p. 8705-8711 7 p. |
article |
20 |
Improved long-term protection against Mycobacterium tuberculosis Beijing/W in mice after intra-dermal inoculation of recombinant BCG expressing latency associated antigens
|
Reece, Stephen T. |
|
2011 |
29 |
47 |
p. 8740-8744 5 p. |
article |
21 |
Increased survival time in mice vaccinated with a branched lysine multiple antigenic peptide containing B- and T-cell epitopes from T. gondii antigens
|
Wang, Yanhua |
|
2011 |
29 |
47 |
p. 8619-8623 5 p. |
article |
22 |
Intranasal Sendai viral vector vaccination is more immunogenic than intramuscular under pre-existing anti-vector antibodies
|
Moriya, Chikaya |
|
2011 |
29 |
47 |
p. 8557-8563 7 p. |
article |
23 |
MAGE-A family: Attractive targets for cancer immunotherapy
|
Sang, Meixiang |
|
2011 |
29 |
47 |
p. 8496-8500 5 p. |
article |
24 |
Missed clinical opportunities: Provider recommendations for HPV vaccination for 11–12 year old girls are limited
|
Vadaparampil, Susan T. |
|
2011 |
29 |
47 |
p. 8634-8641 8 p. |
article |
25 |
Mucosal antibodies induced by tandem repeat of 2F5 epitope block transcytosis of HIV-1
|
Wang, Ji |
|
2011 |
29 |
47 |
p. 8542-8548 7 p. |
article |
26 |
Neuropathology of vaccination in infants and children
|
Rorke-Adams, Lucy B. |
|
2011 |
29 |
47 |
p. 8754-8759 6 p. |
article |
27 |
Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera
|
Draper, Eve |
|
2011 |
29 |
47 |
p. 8585-8590 6 p. |
article |
28 |
Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine
|
Weston, Wayde |
|
2011 |
29 |
47 |
p. 8483-8486 4 p. |
article |
29 |
Planning for influenza vaccination in health care workers: An Intervention Mapping approach
|
Kok, Gerjo |
|
2011 |
29 |
47 |
p. 8512-8519 8 p. |
article |
30 |
Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program
|
Tanuseputro, Peter |
|
2011 |
29 |
47 |
p. 8580-8584 5 p. |
article |
31 |
Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles
|
Zhao, Kai |
|
2011 |
29 |
47 |
p. 8549-8556 8 p. |
article |
32 |
Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination
|
Winnock, M. |
|
2011 |
29 |
47 |
p. 8656-8660 5 p. |
article |
33 |
Rapid and accurate determination of the potency of varicella vaccine by quantitative polymerase chain reaction
|
Russell, Marsha S. |
|
2011 |
29 |
47 |
p. 8490-8495 6 p. |
article |
34 |
Researching routine immunization–do we know what we don’t know?
|
Clements, C. John |
|
2011 |
29 |
47 |
p. 8477-8482 6 p. |
article |
35 |
Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons
|
Wald, Anna |
|
2011 |
29 |
47 |
p. 8520-8529 10 p. |
article |
36 |
Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO®
|
Schuller, Elisabeth |
|
2011 |
29 |
47 |
p. 8669-8676 8 p. |
article |
37 |
Seasonal influenza vaccination in adults: Practice and attitudes about collaborative delivery with community vaccinators
|
Hurley, Laura P. |
|
2011 |
29 |
47 |
p. 8649-8655 7 p. |
article |
38 |
Targeting the tick protective antigen subolesin reduces vector infestations and pathogen infection by Anaplasma marginale and Babesia bigemina
|
Merino, Octavio |
|
2011 |
29 |
47 |
p. 8575-8579 5 p. |
article |
39 |
Therapeutic cancer vaccines: Why so few randomised phase III studies reflect the initial optimism of phase II studies
|
Dalgleish, Angus G. |
|
2011 |
29 |
47 |
p. 8501-8505 5 p. |
article |
40 |
Trivalent and quadrivalent MF59®-adjuvanted influenza vaccine in young children: A dose- and schedule-finding study
|
Della Cioppa, Giovanni |
|
2011 |
29 |
47 |
p. 8696-8704 9 p. |
article |
41 |
Universal peptide vaccines – Optimal peptide vaccine design based on viral sequence conservation
|
Toussaint, Nora C. |
|
2011 |
29 |
47 |
p. 8745-8753 9 p. |
article |
42 |
Viral interference induced by live attenuated virus vaccine (OPV) can prevent otitis media
|
Seppälä, Elina |
|
2011 |
29 |
47 |
p. 8615-8618 4 p. |
article |
43 |
Wide-range protection against avian reovirus conferred by vaccination with representatives of four defined genotypes
|
Lublin, Avishai |
|
2011 |
29 |
47 |
p. 8683-8688 6 p. |
article |